Huapont Life Sciences Co.,Ltd. - Laporan Laba Rugi (TTM)

Huapont Life Sciences Co.,Ltd.
CN ˙ SZSE ˙ CNE000001JJ6
CN¥ 4.91 ↑0.02 (0.41%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Huapont Life Sciences Co.,Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2021
01-01
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 10,485 10,876 11,441 11,446 11,618 12,431 13,011 13,383 13,983 13,232 12,809 12,401 11,904 11,595 11,535 11,648 11,651 11,665 11,570 11,688
Change (%) 3.73 5.19 0.04 1.51 7.00 4.66 2.86 4.48 -5.37 -3.20 -3.18 -4.01 -2.60 -0.52 0.98 0.03 0.11 -0.81 1.02
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5,887 6,469 6,823 6,836 7,204 7,759 8,125 8,415 8,614 7,971 7,672 7,315 7,143 7,208 7,245 7,546 7,564 7,827 7,742 7,859
Change (%) 9.88 5.47 0.19 5.39 7.70 4.71 3.58 2.35 -7.46 -3.75 -4.66 -2.34 0.90 0.51 4.16 0.23 3.48 -1.09 1.51
% of Revenue 56.15 59.48 59.63 59.73 62.01 62.42 62.45 62.88 61.60 60.24 59.90 58.98 60.01 62.17 62.81 64.78 64.92 67.10 66.91 67.24
Gross Operating Profit 4,598 4,407 4,618 4,610 4,414 4,672 4,886 4,968 5,369 5,261 5,137 5,087 4,761 4,387 4,290 4,102 4,088 3,838 3,828 3,829
Change (%) -4.14 4.79 -0.19 -4.25 5.85 4.58 1.68 8.08 -2.00 -2.37 -0.97 -6.40 -7.86 -2.21 -4.38 -0.35 -6.11 -0.24 0.01
% of Revenue 43.85 40.52 40.37 40.27 37.99 37.58 37.55 37.12 38.40 39.76 40.10 41.02 39.99 37.83 37.19 35.22 35.08 32.90 33.09 32.76
SG&A 2,746 2,544 2,662 2,690 2,725 2,777 2,811 2,784 2,903 2,911 2,783 2,798 2,621 2,557 2,573 2,467 2,445 2,279 2,267 2,262
Change (%) -7.37 4.66 1.06 1.30 1.92 1.21 -0.96 4.26 0.29 -4.39 0.54 -6.36 -2.41 0.62 -4.15 -0.87 -6.78 -0.52 -0.22
% of Revenue 26.19 23.39 23.27 23.50 23.46 22.34 21.61 20.80 20.76 22.00 21.73 22.57 22.01 22.06 22.31 21.18 20.99 19.54 19.60 19.36
R&D 285 324 323 323 308 329 339 348 394 385 403 413 425 419 412 398 395 375 388 383
Change (%) 13.85 -0.57 0.17 -4.70 7.01 2.95 2.71 13.13 -2.26 4.72 2.46 2.70 -1.27 -1.68 -3.35 -0.82 -4.99 3.35 -1.37
% of Revenue 2.72 2.98 2.82 2.82 2.65 2.65 2.61 2.60 2.82 2.91 3.15 3.33 3.57 3.61 3.57 3.42 3.39 3.22 3.35 3.27
OpEx 8,940 9,398 9,866 9,932 10,302 10,947 11,360 11,629 12,019 11,357 10,956 10,625 10,309 10,288 10,338 10,518 10,481 10,596 10,521 10,642
Change (%) 5.12 4.98 0.67 3.73 6.26 3.77 2.37 3.36 -5.51 -3.53 -3.02 -2.98 -0.20 0.49 1.74 -0.35 1.10 -0.71 1.15
% of Revenue 85.27 86.41 86.23 86.77 88.67 88.06 87.31 86.89 85.96 85.83 85.53 85.68 86.60 88.73 89.63 90.30 89.95 90.84 90.93 91.05
Operating Income 1,545 1,478 1,575 1,514 1,316 1,484 1,651 1,754 1,963 1,875 1,853 1,776 1,596 1,307 1,197 1,130 1,171 1,068 1,049 1,046
Change (%) -4.30 6.57 -3.90 -13.07 12.77 11.25 6.26 11.92 -4.48 -1.20 -4.15 -10.16 -18.12 -8.42 -5.54 3.57 -8.74 -1.78 -0.36
% of Revenue 14.73 13.59 13.77 13.23 11.33 11.94 12.69 13.11 14.04 14.17 14.47 14.32 13.40 11.27 10.37 9.70 10.05 9.16 9.07 8.95
Interest Expense -554 -561 -540 -505 -471 -462 -446 -445 -447 -434 -420 -404 -362 -344 -346 -348 -358 -350 -336 -326
Change (%) 1.36 -3.82 -6.43 -6.70 -2.01 -3.48 -0.13 0.54 -3.00 -3.20 -3.74 -10.55 -4.99 0.61 0.71 2.69 -2.14 -4.06 -3.01
% of Revenue -5.28 -5.16 -4.72 -4.41 -4.06 -3.71 -3.42 -3.33 -3.20 -3.28 -3.28 -3.26 -3.04 -2.96 -3.00 -2.99 -3.07 -3.00 -2.90 -2.79
Net Income 627 652 690 687 658 668 715 875 864 433 442 261 221 302 281 228 249 -299 -270 -224
Change (%) 3.91 5.94 -0.45 -4.21 1.43 7.04 22.36 -1.19 -49.84 1.96 -41.01 -15.08 36.47 -7.14 -18.55 9.05 -219.99 -9.63 -17.08
% of Revenue 5.98 5.99 6.03 6.01 5.67 5.37 5.49 6.54 6.18 3.28 3.45 2.10 1.86 2.61 2.43 1.96 2.14 -2.56 -2.34 -1.92

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista